Search research articles
Contact Us
Filters
Showing results (1-10 of 28) with videos related to
Page
of 3
Sort By:
Plos One
|
November 22, 2019
Quantum dots reveal heterogeneous membrane diffusivity and dynamic surface density polarization of dopamine transporter
Oleg Kovtun, Ian D Tomlinson, Riley S Ferguson, et al.
Bioorganic & Medicinal Chemistry Letters
|
February 22, 2011
Biotin tethered homotryptamine derivatives: high affinity probes of the human serotonin transporter (hSERT)
Ian D Tomlinson, Hideki Iwamoto, Randy D Blakely, et al.
Chemical Communications (Cambridge, England)
|
May 1, 2012
A flow cytometry-based dopamine transporter binding assay using antagonist-conjugated quantum dots
Oleg Kovtun, Emily J Ross, Ian D Tomlinson, et al.
Bioorganic & Medicinal Chemistry Letters
|
February 28, 2019
Biotinylated-spiperone ligands for quantum dot labeling of the dopamine D2 receptor in live cell cultures
Ian D Tomlinson, Oleg Kovtun, Tiffany M Crescentini, et al.
ACS Chemical Neuroscience
|
January 22, 2013
Serotonin uptake is largely mediated by platelets versus lymphocytes in peripheral blood cells
Brendan S Beikmann, Ian D Tomlinson, Sandra J Rosenthal, et al.
Methods in Molecular Biology (Clifton, N.J.)
|
June 1, 2005
Labeling cell-surface proteins via antibody quantum dot streptavidin conjugates
John N Mason, Ian D Tomlinson, Sandra J Rosenthal, et al.
Methods in Molecular Biology (Clifton, N.J.)
|
June 1, 2005
Peptide-conjugated quantum dots: imaging the angiotensin type 1 receptor in living cells
Ian D Tomlinson, John N Mason, Randy D Blakely, et al.
Bioorganic & Medicinal Chemistry Letters
|
June 21, 2006
High affinity inhibitors of the dopamine transporter (DAT): novel biotinylated ligands for conjugation to quantum dots
Ian D Tomlinson, John N Mason, Randy D Blakely, et al.
Bioorganic & Medicinal Chemistry Letters
|
September 27, 2005
Inhibitors of the serotonin transporter protein (SERT): the design and synthesis of biotinylated derivatives of 3-(1,2,3,6-tetrahydro-pyridin-4-yl)-1H-indoles. High-affinity serotonergic ligands for conjugation with quantum dots
Ian D Tomlinson, John N Mason, Randy D Blakely, et al.
Chemistry & Biology
|
February 1, 2011
Biocompatible quantum dots for biological applications
Sandra J Rosenthal, Jerry C Chang, Oleg Kovtun, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 28) with videos related to
Sort By:
Page
of 3
Plos One
|
November 22, 2019
Quantum dots reveal heterogeneous membrane diffusivity and dynamic surface density polarization of dopamine transporter
Oleg Kovtun, Ian D Tomlinson, Riley S Ferguson, et al.
Bioorganic & Medicinal Chemistry Letters
|
February 22, 2011
Biotin tethered homotryptamine derivatives: high affinity probes of the human serotonin transporter (hSERT)
Ian D Tomlinson, Hideki Iwamoto, Randy D Blakely, et al.
Chemical Communications (Cambridge, England)
|
May 1, 2012
A flow cytometry-based dopamine transporter binding assay using antagonist-conjugated quantum dots
Oleg Kovtun, Emily J Ross, Ian D Tomlinson, et al.
Bioorganic & Medicinal Chemistry Letters
|
February 28, 2019
Biotinylated-spiperone ligands for quantum dot labeling of the dopamine D2 receptor in live cell cultures
Ian D Tomlinson, Oleg Kovtun, Tiffany M Crescentini, et al.
ACS Chemical Neuroscience
|
January 22, 2013
Serotonin uptake is largely mediated by platelets versus lymphocytes in peripheral blood cells
Brendan S Beikmann, Ian D Tomlinson, Sandra J Rosenthal, et al.
Methods in Molecular Biology (Clifton, N.J.)
|
June 1, 2005
Labeling cell-surface proteins via antibody quantum dot streptavidin conjugates
John N Mason, Ian D Tomlinson, Sandra J Rosenthal, et al.
Methods in Molecular Biology (Clifton, N.J.)
|
June 1, 2005
Peptide-conjugated quantum dots: imaging the angiotensin type 1 receptor in living cells
Ian D Tomlinson, John N Mason, Randy D Blakely, et al.
Bioorganic & Medicinal Chemistry Letters
|
June 21, 2006
High affinity inhibitors of the dopamine transporter (DAT): novel biotinylated ligands for conjugation to quantum dots
Ian D Tomlinson, John N Mason, Randy D Blakely, et al.
Bioorganic & Medicinal Chemistry Letters
|
September 27, 2005
Inhibitors of the serotonin transporter protein (SERT): the design and synthesis of biotinylated derivatives of 3-(1,2,3,6-tetrahydro-pyridin-4-yl)-1H-indoles. High-affinity serotonergic ligands for conjugation with quantum dots
Ian D Tomlinson, John N Mason, Randy D Blakely, et al.
Chemistry & Biology
|
February 1, 2011
Biocompatible quantum dots for biological applications
Sandra J Rosenthal, Jerry C Chang, Oleg Kovtun, et al.
Page
of 3